Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acelrx Pharmaceuticals (ACRX)
NASDAQ:ACRX
Holding ACRX?
Track your performance easily
ACRX Stock Chart & Stats
Day’s Range$0.78 - $0.88
52-Week Range― - ―
Previous Close$0.8
Volume243.57K
Average Volume (3M)N/A
Market Cap
$13.37M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 07, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5.00Price Target Upside481.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Acelrx News
PremiumPre-Earnings
Is ACRX a Buy, Before Earnings?
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
20.21% Other Institutional Investors
79.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACRX FAQ
What was Acelrx Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Acelrx Pharmaceuticals’s market cap?
Currently, no data Available
When is Acelrx Pharmaceuticals’s upcoming earnings report date?
Acelrx Pharmaceuticals’s upcoming earnings report date is Mar 07, 2024 which is 288 days ago.
How were Acelrx Pharmaceuticals’s earnings last quarter?
Acelrx Pharmaceuticals released its earnings results on Nov 08, 2023. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.28 by $0.2.
Is Acelrx Pharmaceuticals overvalued?
According to Wall Street analysts Acelrx Pharmaceuticals’s price is currently Undervalued.
Does Acelrx Pharmaceuticals pay dividends?
Acelrx Pharmaceuticals does not currently pay dividends.
What is Acelrx Pharmaceuticals’s EPS estimate?
Acelrx Pharmaceuticals’s EPS estimate is -$0.16.
How many shares outstanding does Acelrx Pharmaceuticals have?
Currently, no data Available
What happened to Acelrx Pharmaceuticals’s price movement after its last earnings report?
Acelrx Pharmaceuticals reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.28. Following the earnings report the stock price went down -11.321%.
Which hedge fund is a major shareholder of Acelrx Pharmaceuticals?
Currently, no hedge funds are holding shares in ACRX
---
Acelrx Stock Smart Score
Company Description
Acelrx Pharmaceuticals
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
---
ACRX Earnings Call
Q3 2023
0:00 / 0:00
---
ACRX Stock 12 Month Forecast
Average Price Target
$5.00
▲(481.40% Upside)
Technical Analysis
Best Analysts Covering ACRX
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-24.68%
reiterated a buy rating 12 months ago
Copying Ed Arce's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -24.68% per trade.
---